| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/07/2006 | US6995174 for inhibiting proteases |
| 02/07/2006 | US6995172 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 02/07/2006 | US6995162 Substituted alkylamine derivatives and methods of use |
| 02/07/2006 | US6995156 Platelet adenosine diphosphate receptor antagonists |
| 02/07/2006 | US6995144 for example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 02/07/2006 | US6995142 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/07/2006 | CA2340202C Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/07/2006 | CA2273479C 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 02/07/2006 | CA2200433C Phenyloxazolidinone antimicrobials |
| 02/02/2006 | WO2006012577A2 Quinazolinone derivatives useful for the regulation of glucose homeostasis and food intake |
| 02/02/2006 | WO2006012374A1 Substituted aryl-amine derivatives and methods of use |
| 02/02/2006 | WO2006011040A1 Quinazolin-4-yl- piperidine and cinnolin-4-yl- piperidine derivatives as pde10 inhibitors for the treatment of cns disorders |
| 02/02/2006 | WO2006010968A1 New aryloxy acetic acid amide derivatives |
| 02/02/2006 | WO2006010966A1 New benzoyl urea derivatives |
| 02/02/2006 | WO2006010964A1 New 4-benzylidene-piperidin derivatives |
| 02/02/2006 | WO2006010756A1 Oxazolidinone compounds and compositions and methods related thereto |
| 02/02/2006 | WO2005115392A3 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors |
| 02/02/2006 | WO2005113511A9 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 02/02/2006 | WO2005072308A9 Cgrp receptor antagonists |
| 02/02/2006 | US20060025600 Process for preparing zolmitriptan compounds |
| 02/02/2006 | US20060025599 Benzyloxy derivatives |
| 02/02/2006 | US20060025591 New uracils having a herbicidal activity |
| 02/02/2006 | US20060025589 2-Thiohydantoine derivative compounds and use thereof for the treatment of diabetes |
| 02/02/2006 | US20060025461 Triazole derivative |
| 02/02/2006 | US20060025457 Isoindoline compounds and methods of their use |
| 02/02/2006 | US20060025451 Novel pyrazole compounds as transforming growth factor (TGF) inhibitors |
| 02/02/2006 | US20060025442 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/02/2006 | US20060025441 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 02/02/2006 | US20060025432 N-[2-[(3-Chloro-2-fluorobenzyl)thio]-6-[(2-hydroxy-1-methylethyl)amino]-4-pyrimidinyl]- 4-morpholinesulfonamide; asthma, antiallergens; rhinitis, chronic obstructive pulmonary disease, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis |
| 02/02/2006 | US20060025425 Benzimidazole and pyridylimidazole derivatives |
| 02/02/2006 | US20060025423 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/02/2006 | US20060025421 Pyridyl piperazines for the treatment of CNS disorders |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025415 Compositions useful as inhibitors of voltage-gated sodium channels |
| 02/02/2006 | US20060025414 Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 02/02/2006 | US20060025413 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 02/02/2006 | US20060025412 Enzyme inhibitors as bactericides for infections |
| 02/02/2006 | US20060025410 2,4-Pyrimidinediamine compounds and their uses |
| 02/02/2006 | US20060025406 Modulators of hepatocyte growth factor/c- Met activity |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | US20060025402 Benzimidazolidinone derivatives as muscarinic agents |
| 02/02/2006 | CA2574685A1 Quinazolin-4-yl- piperidine and cinnolin-4-yl- piperidine derivatives as pde10 inhibitors for the treatment of cns disorders |
| 02/02/2006 | CA2574668A1 Oxazolidinone compounds and compositions and methods related thereto |
| 02/02/2006 | CA2574158A1 New benzoyl urea derivatives |
| 02/02/2006 | CA2574148A1 4-benzylidene-piperidine derivatives |
| 02/02/2006 | CA2573920A1 Histamine-3 receptor antagonists |
| 02/02/2006 | CA2571324A1 Heterocycle-substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/01/2006 | EP1621539A1 Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/01/2006 | EP1621195A2 The use of pyridinic NK-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 02/01/2006 | EP1620434A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/01/2006 | EP1620433A1 Oxazolidinone derivatives as antimicrobials |
| 02/01/2006 | EP1620431A1 3-carbonylaminothiophenes and their use as fungicides |
| 02/01/2006 | EP1620411A2 Inhibitors of akt activity |
| 02/01/2006 | EP1620410A1 Use of derivatives of 2, 4-dihydro- 1,2,4 triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo) |
| 02/01/2006 | EP1620110A2 Immunomodulator phosphonate conjugates |
| 02/01/2006 | EP1620108A2 Pyrazole-amine compounds useful as kinase inhibitors |
| 02/01/2006 | EP1620092A2 Compounds, compositions, and methods |
| 02/01/2006 | EP1620091A2 Inhibitors of glutaminyl cyclase |
| 02/01/2006 | EP1620088A2 Indole acetic acid derivatives and their use as pharmaceutical agents |
| 02/01/2006 | EP1620086A1 Compounds that modulate ppar activity and methods of preparation |
| 02/01/2006 | EP1500654B1 Benzoxazinone derivatives, the preparation and use thereof as medicaments |
| 02/01/2006 | EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 02/01/2006 | EP1119563B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 02/01/2006 | EP0970057B1 Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof |
| 02/01/2006 | CN1729178A N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| 02/01/2006 | CN1729177A New uracils having a herbicidal activity |
| 02/01/2006 | CN1729175A Tetrahydroquinoline derivatives |
| 02/01/2006 | CN1728999A Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/01/2006 | CN1239500C Oxazole substituted fulgenimide photochronic compound and its synthesis and use |
| 02/01/2006 | CN1239497C Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
| 02/01/2006 | CN1239496C Respiratory syncytial virus replication inhibitors |
| 01/31/2006 | US6992096 translation of mRNA is allowed to continue past a nonsense mutation point, resulting in the production of a full length protein; genetic disorders; 3-(5-p-tolyl-[1,2,4]oxadiazol-3-yl)-benzoic acid |
| 01/31/2006 | US6992083 Benzoxazol derivatives |
| 01/31/2006 | US6992044 Substituted phenyluracils |
| 01/31/2006 | CA2224635C Pyridine derivatives, process for preparing the same, and intermediate therefor |
| 01/31/2006 | CA2119261C Novel sidechain-bearing taxanes and intermediates thereof |
| 01/26/2006 | WO2006010095A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 01/26/2006 | WO2006010094A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors |
| 01/26/2006 | WO2006009907A2 Isoxazolidine compounds for treatment of bacterial infections |
| 01/26/2006 | WO2006009726A2 Substituted urea derivatives for treating cardiac diseases |
| 01/26/2006 | WO2006008260A1 Dimeric piperidine derivatives |
| 01/26/2006 | WO2005116009B1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors |
| 01/26/2006 | WO2005097788A3 Sulfonamides and uses thereof |
| 01/26/2006 | WO2005085234A3 Bycyclic anthranilamide derivatives useful as insecticides |
| 01/26/2006 | WO2005077463A3 Ligand for a monoamine receptor or transporter for treating addiction or dependence |
| 01/26/2006 | US20060020012 Pyrazole derivatives |
| 01/26/2006 | US20060020008 Compounds, compositions and methods |
| 01/26/2006 | US20060020004 Isoxazolidine compounds for treatment of bacterial infections |
| 01/26/2006 | US20060019997 Triazole compounds and their use as metabotropic glutamate receptor antagonists |
| 01/26/2006 | US20060019996 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/26/2006 | US20060019994 I-sulphonlyl piperidine derivatives |
| 01/26/2006 | US20060019975 Novel piperidyl derivatives of quinazoline and isoquinoline |
| 01/26/2006 | US20060019956 Compositions useful as inhibitors of rock and other protein kinases |
| 01/26/2006 | US20060019953 Pyridine inhibitors of ERK2 and uses thereof |
| 01/26/2006 | US20060019951 Vacuolins |
| 01/26/2006 | US20060019949 Alzheimer's disease, Parkinson's disease, Huntington's disease, neuroprotection, schizophrenia, anxiety, pain, respiration deficits, depression, ADHD, drug addiction, such as amphetamine, cocaine, opioids, ethanol, nicotine, cannabinoids; asthma, allergic responses, hypoxia, cardiovasular disorders |
| 01/26/2006 | US20060019948 Methylidene-D-xylopyranosyl- and oxo-D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 01/26/2006 | US20060019947 Therapeutic chromone compounds |
| 01/26/2006 | US20060019253 Polymerase chain reaction analysis by mixing a dsDNA binding dye with a sample of target nucleic acid and primers configured for amplifying; melting the amplified target nucleic acid to generate a melting curve; plotting; repeating; comparison; melting curve difference for each target nucleic acid |
| 01/26/2006 | US20060018825 Probe for diseases with amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |